Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer.

Cancers (Basel) · 2019 · PMC6895788 · PMID 31703359

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Though the use of fluoropyrimidine-based therapy showed a trend of better survival benefit as compared to the use of a combination of immunotherapy and gemcitabine (HR: 0.77; 95% CI: 0.51–1.16) and the use of a combination of taxanes and gemcitabine (HR: 0.80; 95% CI: 0.59–1.10), there was no significant difference. 2.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.